After more than 10,000 years of use, the ancient cultures and indigenous communities who use plant medicines may hold lessons ...
The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) ...
There's a psychedelic Renaissance underway as psychoactive substances like psilocybin, DMT, and MDMA are making headway into ...
The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...
The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized ...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic- ...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...